Share Price and Basic Stock Data
Last Updated: January 10, 2026, 7:38 am
| PEG Ratio | 2.90 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vishnu Chemicals Ltd operates in the chemicals sector, specifically focusing on inorganic chemicals. The company reported a market capitalization of ₹3,583 Cr and a current share price of ₹532. Over the years, revenue has shown a positive trajectory, with sales increasing from ₹418 Cr in March 2015 to ₹1,391 Cr in March 2023. The trailing twelve months (TTM) sales stood at ₹1,512 Cr, indicating a strong operational performance. However, the revenue for March 2024 is projected to decline to ₹1,213 Cr, reflecting potential challenges in sustaining growth momentum. Quarterly sales figures have shown fluctuations, with a recent dip to ₹301 Cr in June 2023, followed by a recovery to ₹308 Cr in September 2023. The company’s ability to adapt to market conditions will be critical in maintaining its revenue growth in a competitive environment.
Profitability and Efficiency Metrics
Vishnu Chemicals reported a net profit of ₹138 Cr for the trailing twelve months, achieving a return on equity (ROE) of 15.5% and a return on capital employed (ROCE) of 18.1%. The operating profit margin (OPM) stood at 15% for the current fiscal year, reflecting the company’s efforts to manage costs while maximizing revenue. However, the OPM has experienced fluctuations, declining to 13% in the recent quarter ending December 2023, which could suggest increasing operational challenges. The interest coverage ratio (ICR) of 6.53x indicates that the company can comfortably meet its interest obligations, providing a cushion against financial distress. Efficiency metrics such as the cash conversion cycle (CCC) of 145 days highlight the time taken to convert investments into cash flow, a factor that the management must optimize to enhance liquidity and operational efficiency.
Balance Sheet Strength and Financial Ratios
Vishnu Chemicals has reported total reserves of ₹987 Cr and borrowings of ₹418 Cr, reflecting a solid balance sheet. The company’s debt-to-equity ratio of 0.36x indicates a conservative use of leverage, which is lower than many of its industry peers, suggesting a lower risk profile. The current ratio of 1.70x signifies that the company possesses adequate short-term assets to cover its liabilities, ensuring liquidity. Furthermore, the price-to-book value (P/BV) ratio is recorded at 3.32x, which is relatively high compared to typical sector ranges, indicating a premium valuation by the market. The reported book value per share has increased to ₹137.67, showing strength in asset management and shareholder equity. However, the rising borrowings alongside a declining operating profit margin could pose risks to financial stability if not managed effectively.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vishnu Chemicals reveals a strong promoter holding of 69.21%, indicating substantial insider confidence in the company’s future prospects. Foreign institutional investors (FIIs) have increased their stake slightly to 2.23%, while domestic institutional investors (DIIs) hold 5.59%. The public shareholding stands at 22.97%, with a total of 31,754 shareholders, reflecting a growing interest among retail investors. Over the past year, promoter holdings have slightly decreased from 75% in December 2022, which may raise concerns about insider confidence. Additionally, the increase in public and institutional holdings could be interpreted as a positive sign of market sentiment, as investors seek to capitalize on the company’s growth potential amidst a competitive landscape. Maintaining investor confidence will be crucial for the company as it navigates market challenges ahead.
Outlook, Risks, and Final Insight
Looking ahead, Vishnu Chemicals faces both opportunities and risks that could impact its performance. The company’s solid ROE and ROCE indicate efficient capital use, while its ability to adapt to fluctuating market conditions will be vital for sustaining growth. However, potential risks include declining sales projections and a drop in operating profit margins, which could affect profitability. Additionally, while the company’s debt levels are manageable, any increase in interest rates could elevate financial risks. The management’s focus on optimizing operational efficiency and improving cash flows will be essential in addressing these challenges. If Vishnu Chemicals can effectively navigate these risks while leveraging its strengths, including strong promoter confidence and a solid balance sheet, it could position itself well for future growth in the chemicals sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,607 Cr. | 40.2 | 125/39.1 | 130 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 15.0 Cr. | 29.9 | 45.9/25.8 | 65.0 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 211 Cr. | 269 | 356/238 | 12.6 | 211 | 2.98 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,369 Cr. | 516 | 728/408 | 31.1 | 157 | 0.58 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 336 Cr. | 430 | 503/376 | 16.4 | 144 | 0.70 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,679.00 Cr | 377.42 | 148.78 | 156.25 | 0.50% | 13.95% | 10.65% | 6.18 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 371 | 325 | 336 | 301 | 308 | 304 | 300 | 339 | 344 | 371 | 393 | 347 | 401 |
| Expenses | 312 | 273 | 275 | 250 | 262 | 263 | 237 | 283 | 299 | 308 | 329 | 291 | 343 |
| Operating Profit | 59 | 52 | 61 | 51 | 46 | 41 | 64 | 56 | 45 | 64 | 64 | 56 | 58 |
| OPM % | 16% | 16% | 18% | 17% | 15% | 13% | 21% | 16% | 13% | 17% | 16% | 16% | 15% |
| Other Income | 4 | 6 | 3 | 2 | 3 | 4 | 3 | 3 | 4 | 3 | 6 | 5 | 9 |
| Interest | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 8 | 8 | 12 |
| Depreciation | 7 | 7 | 7 | 7 | 9 | 9 | 9 | 9 | 9 | 12 | 8 | 10 | 10 |
| Profit before tax | 48 | 42 | 49 | 37 | 31 | 27 | 49 | 40 | 30 | 44 | 53 | 42 | 46 |
| Tax % | 27% | 25% | 27% | 23% | 22% | 23% | 43% | 24% | 25% | 23% | 27% | 23% | 28% |
| Net Profit | 35 | 32 | 36 | 29 | 24 | 21 | 28 | 30 | 23 | 34 | 39 | 32 | 33 |
| EPS in Rs | 5.88 | 5.32 | 5.97 | 4.79 | 3.66 | 3.17 | 4.23 | 4.65 | 3.49 | 5.25 | 5.78 | 4.79 | 4.88 |
Last Updated: December 28, 2025, 2:01 pm
Below is a detailed analysis of the quarterly data for Vishnu Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 401.00 Cr.. The value appears strong and on an upward trend. It has increased from 347.00 Cr. (Jun 2025) to 401.00 Cr., marking an increase of 54.00 Cr..
- For Expenses, as of Sep 2025, the value is 343.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 291.00 Cr. (Jun 2025) to 343.00 Cr., marking an increase of 52.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Jun 2025) to 58.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Sep 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Jun 2025) to 15.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Jun 2025) to 9.00 Cr., marking an increase of 4.00 Cr..
- For Interest, as of Sep 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Jun 2025) to 12.00 Cr., marking an increase of 4.00 Cr..
- For Depreciation, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 10.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Jun 2025) to 46.00 Cr., marking an increase of 4.00 Cr..
- For Tax %, as of Sep 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Jun 2025) to 28.00%, marking an increase of 5.00%.
- For Net Profit, as of Sep 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 32.00 Cr. (Jun 2025) to 33.00 Cr., marking an increase of 1.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 4.88. The value appears strong and on an upward trend. It has increased from 4.79 (Jun 2025) to 4.88, marking an increase of 0.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:24 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 418 | 480 | 507 | 643 | 769 | 674 | 679 | 1,069 | 1,391 | 1,213 | 1,447 | 1,512 |
| Expenses | 339 | 396 | 441 | 562 | 667 | 591 | 600 | 911 | 1,160 | 1,010 | 1,217 | 1,270 |
| Operating Profit | 79 | 84 | 66 | 81 | 102 | 82 | 79 | 158 | 231 | 202 | 229 | 241 |
| OPM % | 19% | 18% | 13% | 13% | 13% | 12% | 12% | 15% | 17% | 17% | 16% | 16% |
| Other Income | 1 | 2 | 7 | 8 | 3 | 7 | 3 | 6 | 15 | 12 | 15 | 23 |
| Interest | 34 | 37 | 44 | 49 | 47 | 39 | 27 | 28 | 35 | 37 | 38 | 39 |
| Depreciation | 12 | 13 | 16 | 19 | 21 | 20 | 20 | 23 | 26 | 34 | 38 | 40 |
| Profit before tax | 34 | 36 | 14 | 22 | 37 | 30 | 34 | 112 | 185 | 144 | 168 | 185 |
| Tax % | 36% | 41% | 52% | 35% | 35% | 27% | -1% | 28% | 26% | 30% | 25% | |
| Net Profit | 22 | 21 | 7 | 14 | 24 | 22 | 34 | 81 | 137 | 101 | 127 | 138 |
| EPS in Rs | 3.66 | 3.56 | 1.10 | 2.42 | 4.08 | 3.72 | 5.78 | 13.63 | 22.86 | 15.43 | 18.81 | 20.70 |
| Dividend Payout % | 11% | 6% | 0% | 8% | 5% | 5% | 3% | 3% | 2% | 2% | 2% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -4.55% | -66.67% | 100.00% | 71.43% | -8.33% | 54.55% | 138.24% | 69.14% | -26.28% | 25.74% |
| Change in YoY Net Profit Growth (%) | 0.00% | -62.12% | 166.67% | -28.57% | -79.76% | 62.88% | 83.69% | -69.10% | -95.41% | 52.02% |
Vishnu Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 17% |
| 3 Years: | 11% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 42% |
| 3 Years: | 16% |
| TTM: | 25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 75% |
| 3 Years: | 6% |
| 1 Year: | 19% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 22% |
| 3 Years: | 21% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:12 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 13 | 13 | 13 |
| Reserves | 79 | 106 | 85 | 99 | 130 | 148 | 184 | 265 | 402 | 688 | 913 | 987 |
| Borrowings | 225 | 263 | 322 | 381 | 348 | 328 | 336 | 365 | 379 | 315 | 342 | 418 |
| Other Liabilities | 177 | 239 | 275 | 289 | 266 | 247 | 242 | 274 | 258 | 310 | 366 | 409 |
| Total Liabilities | 492 | 620 | 694 | 782 | 757 | 736 | 773 | 916 | 1,052 | 1,326 | 1,635 | 1,827 |
| Fixed Assets | 186 | 202 | 290 | 349 | 350 | 338 | 387 | 463 | 465 | 635 | 702 | 778 |
| CWIP | 44 | 66 | 62 | 17 | 19 | 36 | 24 | 5 | 98 | 16 | 69 | 56 |
| Investments | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 3 | 2 | 2 | 0 | 0 |
| Other Assets | 262 | 352 | 342 | 415 | 387 | 360 | 361 | 444 | 488 | 675 | 864 | 993 |
| Total Assets | 492 | 620 | 694 | 782 | 757 | 736 | 773 | 916 | 1,052 | 1,326 | 1,635 | 1,827 |
Below is a detailed analysis of the balance sheet data for Vishnu Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 987.00 Cr.. The value appears strong and on an upward trend. It has increased from 913.00 Cr. (Mar 2025) to 987.00 Cr., marking an increase of 74.00 Cr..
- For Borrowings, as of Sep 2025, the value is 418.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 342.00 Cr. (Mar 2025) to 418.00 Cr., marking an increase of 76.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 409.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 366.00 Cr. (Mar 2025) to 409.00 Cr., marking an increase of 43.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,827.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,635.00 Cr. (Mar 2025) to 1,827.00 Cr., marking an increase of 192.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 778.00 Cr.. The value appears strong and on an upward trend. It has increased from 702.00 Cr. (Mar 2025) to 778.00 Cr., marking an increase of 76.00 Cr..
- For CWIP, as of Sep 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 993.00 Cr.. The value appears strong and on an upward trend. It has increased from 864.00 Cr. (Mar 2025) to 993.00 Cr., marking an increase of 129.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,827.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,635.00 Cr. (Mar 2025) to 1,827.00 Cr., marking an increase of 192.00 Cr..
Notably, the Reserves (987.00 Cr.) exceed the Borrowings (418.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -146.00 | -179.00 | -256.00 | -300.00 | -246.00 | -246.00 | -257.00 | -207.00 | -148.00 | -113.00 | -113.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 78 | 88 | 69 | 82 | 64 | 49 | 62 | 65 | 47 | 69 | 74 |
| Inventory Days | 230 | 314 | 269 | 212 | 201 | 252 | 243 | 143 | 142 | 263 | 242 |
| Days Payable | 117 | 225 | 201 | 207 | 147 | 167 | 174 | 146 | 120 | 187 | 172 |
| Cash Conversion Cycle | 191 | 176 | 137 | 87 | 117 | 134 | 131 | 63 | 69 | 145 | 145 |
| Working Capital Days | 37 | 3 | -70 | -24 | -3 | 2 | 6 | 10 | 21 | 54 | 67 |
| ROCE % | 21% | 14% | 16% | 17% | 14% | 12% | 24% | 30% | 20% | 18% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Franklin India Small Cap Fund | 1,659,420 | 0.65 | 87.34 | N/A | N/A | N/A |
| Bandhan Small Cap Fund | 961,765 | 0.28 | 50.62 | 652,741 | 2025-11-03 14:33:44 | 47.34% |
| ITI Multi Cap Fund | 298,690 | 1.17 | 15.72 | 290,199 | 2025-12-15 07:00:15 | 2.93% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.23 | 15.90 | 22.86 | 68.13 | 28.88 |
| Diluted EPS (Rs.) | 19.23 | 15.90 | 22.86 | 68.13 | 28.88 |
| Cash EPS (Rs.) | 24.48 | 20.55 | 27.29 | 87.37 | 45.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 137.67 | 107.00 | 69.37 | 231.77 | 164.19 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 137.67 | 107.00 | 69.37 | 231.77 | 164.19 |
| Revenue From Operations / Share (Rs.) | 214.89 | 185.05 | 232.88 | 894.86 | 568.12 |
| PBDIT / Share (Rs.) | 36.20 | 32.66 | 41.07 | 135.12 | 67.19 |
| PBIT / Share (Rs.) | 30.53 | 27.54 | 36.63 | 115.88 | 50.20 |
| PBT / Share (Rs.) | 24.99 | 21.94 | 31.05 | 94.03 | 28.46 |
| Net Profit / Share (Rs.) | 18.81 | 15.43 | 22.86 | 68.13 | 28.88 |
| NP After MI And SOA / Share (Rs.) | 18.81 | 15.43 | 22.86 | 68.13 | 28.88 |
| PBDIT Margin (%) | 16.84 | 17.64 | 17.63 | 15.09 | 11.82 |
| PBIT Margin (%) | 14.20 | 14.88 | 15.73 | 12.94 | 8.83 |
| PBT Margin (%) | 11.62 | 11.85 | 13.33 | 10.50 | 5.01 |
| Net Profit Margin (%) | 8.75 | 8.33 | 9.81 | 7.61 | 5.08 |
| NP After MI And SOA Margin (%) | 8.75 | 8.33 | 9.81 | 7.61 | 5.08 |
| Return on Networth / Equity (%) | 13.66 | 14.41 | 32.95 | 29.39 | 17.58 |
| Return on Capital Employeed (%) | 17.99 | 19.84 | 31.99 | 25.40 | 13.47 |
| Return On Assets (%) | 7.75 | 7.62 | 12.99 | 8.89 | 4.46 |
| Long Term Debt / Equity (X) | 0.17 | 0.11 | 0.34 | 0.46 | 0.50 |
| Total Debt / Equity (X) | 0.36 | 0.34 | 0.72 | 1.04 | 1.17 |
| Asset Turnover Ratio (%) | 0.97 | 1.02 | 1.40 | 1.18 | 0.78 |
| Current Ratio (X) | 1.70 | 1.58 | 1.28 | 1.13 | 1.06 |
| Quick Ratio (X) | 0.88 | 0.81 | 0.71 | 0.67 | 0.48 |
| Inventory Turnover Ratio (X) | 4.02 | 2.69 | 3.89 | 2.86 | 1.60 |
| Dividend Payout Ratio (NP) (%) | 1.55 | 2.59 | 1.74 | 1.46 | 3.46 |
| Dividend Payout Ratio (CP) (%) | 1.19 | 1.94 | 1.46 | 1.14 | 2.18 |
| Earning Retention Ratio (%) | 98.45 | 97.41 | 98.26 | 98.54 | 96.54 |
| Cash Earning Retention Ratio (%) | 98.81 | 98.06 | 98.54 | 98.86 | 97.82 |
| Interest Coverage Ratio (X) | 6.53 | 5.83 | 7.35 | 6.19 | 3.09 |
| Interest Coverage Ratio (Post Tax) (X) | 4.40 | 3.75 | 5.09 | 4.12 | 2.33 |
| Enterprise Value (Cr.) | 3341.23 | 2341.14 | 1974.14 | 2250.42 | 636.06 |
| EV / Net Operating Revenue (X) | 2.31 | 1.93 | 1.42 | 2.11 | 0.93 |
| EV / EBITDA (X) | 13.71 | 10.94 | 8.05 | 13.94 | 7.92 |
| MarketCap / Net Operating Revenue (X) | 2.13 | 1.72 | 1.16 | 1.78 | 0.50 |
| Retention Ratios (%) | 98.44 | 97.40 | 98.25 | 98.53 | 96.53 |
| Price / BV (X) | 3.32 | 2.98 | 3.90 | 6.87 | 1.74 |
| Price / Net Operating Revenue (X) | 2.13 | 1.72 | 1.16 | 1.78 | 0.50 |
| EarningsYield | 0.04 | 0.04 | 0.08 | 0.04 | 0.10 |
After reviewing the key financial ratios for Vishnu Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 19.23. This value is within the healthy range. It has increased from 15.90 (Mar 24) to 19.23, marking an increase of 3.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 19.23. This value is within the healthy range. It has increased from 15.90 (Mar 24) to 19.23, marking an increase of 3.33.
- For Cash EPS (Rs.), as of Mar 25, the value is 24.48. This value is within the healthy range. It has increased from 20.55 (Mar 24) to 24.48, marking an increase of 3.93.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 137.67. It has increased from 107.00 (Mar 24) to 137.67, marking an increase of 30.67.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 137.67. It has increased from 107.00 (Mar 24) to 137.67, marking an increase of 30.67.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 214.89. It has increased from 185.05 (Mar 24) to 214.89, marking an increase of 29.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 36.20. This value is within the healthy range. It has increased from 32.66 (Mar 24) to 36.20, marking an increase of 3.54.
- For PBIT / Share (Rs.), as of Mar 25, the value is 30.53. This value is within the healthy range. It has increased from 27.54 (Mar 24) to 30.53, marking an increase of 2.99.
- For PBT / Share (Rs.), as of Mar 25, the value is 24.99. This value is within the healthy range. It has increased from 21.94 (Mar 24) to 24.99, marking an increase of 3.05.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 18.81. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 18.81, marking an increase of 3.38.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.81. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 18.81, marking an increase of 3.38.
- For PBDIT Margin (%), as of Mar 25, the value is 16.84. This value is within the healthy range. It has decreased from 17.64 (Mar 24) to 16.84, marking a decrease of 0.80.
- For PBIT Margin (%), as of Mar 25, the value is 14.20. This value is within the healthy range. It has decreased from 14.88 (Mar 24) to 14.20, marking a decrease of 0.68.
- For PBT Margin (%), as of Mar 25, the value is 11.62. This value is within the healthy range. It has decreased from 11.85 (Mar 24) to 11.62, marking a decrease of 0.23.
- For Net Profit Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 8.33 (Mar 24) to 8.75, marking an increase of 0.42.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.75. This value is within the healthy range. It has increased from 8.33 (Mar 24) to 8.75, marking an increase of 0.42.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.66. This value is below the healthy minimum of 15. It has decreased from 14.41 (Mar 24) to 13.66, marking a decrease of 0.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.99. This value is within the healthy range. It has decreased from 19.84 (Mar 24) to 17.99, marking a decrease of 1.85.
- For Return On Assets (%), as of Mar 25, the value is 7.75. This value is within the healthy range. It has increased from 7.62 (Mar 24) to 7.75, marking an increase of 0.13.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 0.2. It has increased from 0.11 (Mar 24) to 0.17, marking an increase of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.36. This value is within the healthy range. It has increased from 0.34 (Mar 24) to 0.36, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.97. It has decreased from 1.02 (Mar 24) to 0.97, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 1.70, marking an increase of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has increased from 0.81 (Mar 24) to 0.88, marking an increase of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.02. This value is within the healthy range. It has increased from 2.69 (Mar 24) to 4.02, marking an increase of 1.33.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 20. It has decreased from 2.59 (Mar 24) to 1.55, marking a decrease of 1.04.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 20. It has decreased from 1.94 (Mar 24) to 1.19, marking a decrease of 0.75.
- For Earning Retention Ratio (%), as of Mar 25, the value is 98.45. This value exceeds the healthy maximum of 70. It has increased from 97.41 (Mar 24) to 98.45, marking an increase of 1.04.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 98.81. This value exceeds the healthy maximum of 70. It has increased from 98.06 (Mar 24) to 98.81, marking an increase of 0.75.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.53. This value is within the healthy range. It has increased from 5.83 (Mar 24) to 6.53, marking an increase of 0.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.40. This value is within the healthy range. It has increased from 3.75 (Mar 24) to 4.40, marking an increase of 0.65.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,341.23. It has increased from 2,341.14 (Mar 24) to 3,341.23, marking an increase of 1,000.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 1.93 (Mar 24) to 2.31, marking an increase of 0.38.
- For EV / EBITDA (X), as of Mar 25, the value is 13.71. This value is within the healthy range. It has increased from 10.94 (Mar 24) to 13.71, marking an increase of 2.77.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 1.72 (Mar 24) to 2.13, marking an increase of 0.41.
- For Retention Ratios (%), as of Mar 25, the value is 98.44. This value exceeds the healthy maximum of 70. It has increased from 97.40 (Mar 24) to 98.44, marking an increase of 1.04.
- For Price / BV (X), as of Mar 25, the value is 3.32. This value exceeds the healthy maximum of 3. It has increased from 2.98 (Mar 24) to 3.32, marking an increase of 0.34.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 1.72 (Mar 24) to 2.13, marking an increase of 0.41.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vishnu Chemicals Ltd:
- Net Profit Margin: 8.75%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.99% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.66% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.88
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.3 (Industry average Stock P/E: 148.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.36
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.75%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | Plot No. C-23, Road No. 8, Film Nagar, Jubilee Hills, Hyderabad Telangana 500096 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Cherukuri Krishna Murthy | Chairman & Managing Director |
| Mr. Cherukuri Siddartha | Joint Managing Director |
| Mrs. Cherukuri Manjula | Non Executive Director |
| Mr. Tirthankar Mitra | Independent Director |
| Mr. Naga Bhushan Bhagwat | Independent Director |
| Mr. Veeramachaneni Vimalanand | Independent Director |
| Dr. Sita Vanka | Independent Director |
FAQ
What is the intrinsic value of Vishnu Chemicals Ltd?
Vishnu Chemicals Ltd's intrinsic value (as of 12 January 2026) is ₹467.72 which is 10.23% lower the current market price of ₹521.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,505 Cr. market cap, FY2025-2026 high/low of ₹596/336, reserves of ₹987 Cr, and liabilities of ₹1,827 Cr.
What is the Market Cap of Vishnu Chemicals Ltd?
The Market Cap of Vishnu Chemicals Ltd is 3,505 Cr..
What is the current Stock Price of Vishnu Chemicals Ltd as on 12 January 2026?
The current stock price of Vishnu Chemicals Ltd as on 12 January 2026 is ₹521.
What is the High / Low of Vishnu Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vishnu Chemicals Ltd stocks is ₹596/336.
What is the Stock P/E of Vishnu Chemicals Ltd?
The Stock P/E of Vishnu Chemicals Ltd is 25.3.
What is the Book Value of Vishnu Chemicals Ltd?
The Book Value of Vishnu Chemicals Ltd is 149.
What is the Dividend Yield of Vishnu Chemicals Ltd?
The Dividend Yield of Vishnu Chemicals Ltd is 0.06 %.
What is the ROCE of Vishnu Chemicals Ltd?
The ROCE of Vishnu Chemicals Ltd is 18.1 %.
What is the ROE of Vishnu Chemicals Ltd?
The ROE of Vishnu Chemicals Ltd is 15.5 %.
What is the Face Value of Vishnu Chemicals Ltd?
The Face Value of Vishnu Chemicals Ltd is 2.00.